Older Patients (pts) With Treatment-Naive Chronic Lymphocytic Leukemia (CLL) Treated With Ibrutinib (ibr): Prolonged Improvement in Patient-Reported Outcomes (PROs) and Well-being in RESONATE-2 Owen, C., Tedeschi, A., Coutre, S., Dean, J. P., Burger, J. A., Kipps, T. J. WILEY. 2018: S127

View details for Web of Science ID 000430468400375